Jonathan CP Roos (PMFA)

Harvard, Cambridge & Moorfields-trained Consultant Oculoplastic Surgeon and academic based in London at www.FaceRestoration.com. Publishes in the world’s leading medical journals and lectures internationally on aesthetics, eyelid diseases and thyroid eyes.

JOURNAL REVIEWED: New England Journal of Medicine | Ophthalmic Epidemiology

Latest Contribution

Is an increased homocysteine level associated with greater risk of AMD?

1 June 2015 | | Retina / Uvea / Vitreous | Age-related macular degeneration, Women's Health Study, homocysteine, prospective cohort, risk factor

Basic research studies have implicated homocysteine in causing vascular endothelial dysfunction and inflammation, and this has been borne out in large observational studies which suggested that elevated homocysteine is associated with increased risk of cardiovascular disease. In order to determine...

Are retinal vein occlusions seasonal? And if so why might that be?

1 June 2015 | | Retina / Uvea / Vitreous | Central retinal vein occlusion, Sweden, incidence, seasonality, vitamin D

Some studies have reported a strong seasonal pattern to central retinal vein occlusion (CRVO) occurrence with a peak in January, but other studies have failed to replicate this finding. The authors sought to determine data for Stockholm’s seasonal variation in...

A randomised, controlled trial of oral propranolol in infantile haemangioma

1 April 2015 | | Oculoplastics, Orbit

Since its use was first reported in the New England Journal in 2008, propranolol has become the preferred treatment for infantile haemangiomas. However, there is no consensus as to the optimum dose or duration of treatment and there is a...